Elevance Health
1,612 hedge funds and large institutions have $76.9B invested in Elevance Health in 2026 Q2 according to their latest regulatory filings, with 262 funds opening new positions, 596 increasing their positions, 549 reducing their positions, and 104 closing their positions.
152% more first-time investments, than exits
New positions opened: 262 | Existing positions closed: 104
35% more capital invested
Capital invested by funds: $57.1B → $76.9B (+$19.8B)
30% more funds holding in top 10
Funds holding in top 10: 20 → 26 (+6)
14% more call options, than puts
Call options by funds: $543M | Put options by funds: $475M
9% more funds holding
Funds holding: 1,473 → 1,612 (+139)
3.44% more ownership
Funds ownership: 88.33% → 91.77% (+3.4%)
9% more repeat investments, than reductions
Existing positions increased: 596 | Existing positions reduced: 549
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$689M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$429M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$365M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$349M |
| 5 |
AACR
ACR Alpine Capital Research
St. Louis,
Missouri
|
+$274M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$389M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$338M |
| 3 |
BlackRock
New York
|
-$332M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$271M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$243M |
ELV Hedge Fund Activity: Q2 2026 in Review
1,612 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2026, worth a combined $76.9B — up 35% from $57.1B a quarter earlier.
Buyers outnumbered sellers: 262 funds opened new ELV positions and 104 closed out — a net gain of 158 holders — while 596 added to existing stakes and 549 trimmed.
The largest buyer was Citigroup, adding an estimated $689M. The largest seller was Amundi, cutting an estimated $389M.
- 1,612 institutional investors held Elevance Health (ELV) as of Q2 2026, up from 1,473 in Q1 2026.
- Funds reported $76.9B of Elevance Health stock for Q2 2026, up 35% quarter-over-quarter.
- 262 funds opened new Elevance Health positions in Q2 2026 and 104 closed out, a net change of +158 holders.
- The largest Elevance Health buyer in Q2 2026 was Citigroup, an estimated $689M added.
- The largest Elevance Health seller in Q2 2026 was Amundi, an estimated $389M sold.
Based on aggregated 13F filings for Q2 2026.